top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
Autore Tagit Oya
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (296 p.)
Soggetto topico Technology: general issues
History of engineering & technology
Materials science
Soggetto non controllato poly(lactic-co-glycolic acid) (PLGA)
blood–brain barrier (BBB)
current Good Manufacturing Practice (cGMP)
Food and Drug Administration (FDA)
nanotechnology
PLGA nanoparticles
neurodegenerative diseases
drug delivery
central nervous system
neuroprotective drugs
fluorescent labeling
DiI
coumarin 6
rhodamine 123
Cy5.5
quantum yield
brightness
stability of fluorescent label
confocal microscopy
intracellular internalization
in vivo neuroimaging
double-emulsion method
dry powder inhalation
antigen release
porous PLGA particles
microfluidics
methotrexate
chitosan
PLA/PLGA
sustained release
micro-implant
animal model
minimally invasive
drug delivery system
nanoparticles
poly (lactic-co-glycolic acid) (PLGA)
microfluidic
pharmacokinetics (PK) and biodistribution
atorvastatin calcium
poly(lactide-co-glycolide)
polymeric nanoparticles
carrageenan induced inflammation
anti-inflammatory
radiolabeled nanoparticles
nuclear medicine
photothermal therapy
phthalocyanine
SKOVip-kat
Katushka
TurboFP635
JO-4
PLGA
orthotopic tumors
3D culture
spheroids
poly(lactic-co-glycolic acid)
nanomedicine
scale-up manufacturing
clinical translation
inline sonication
tangential flow filtration
lyophilization
downstream processing
H. pylori
design of experiments
poly(lactic-co-glycolic) acid
size
cancer
chemoimmunotherapy
immunogenic cell death
immune checkpoint blockade
PNA5 glycopeptide
mas receptor
angiotensin
PLGA diblock copolymer
ester and acid-end capped
double emulsion solvent evaporation
biocompatible
biodegradable
cardiovascular
nanoparticle
solid-state characterization
in vitro
drug release kinetics modeling
PEGylation
amine
emulsion
polyvinyl alcohol (PVA)
Pluronic triblock copolymer
trehalose
sucrose
Indomethacin
solvents
stabilizers
morphology
particle-size
encapsulation
drug release
cytotoxicity
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease
Record Nr. UNINA-9910580215803321
Tagit Oya  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
PLGA Based Drug Carrier and Pharmaceutical Applications
PLGA Based Drug Carrier and Pharmaceutical Applications
Autore Pereira Maria Carmo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (328 p.)
Soggetto topico Medicine
Soggetto non controllato PLGA
nanoscaled drug delivery
LED
cancer
serum stability
reactive oxygen species
cellular uptake
terahertz spectroscopy
microspheres
drug delivery
formulation development
molecular mobility
vitamin E
tocopherol
PLA
core-shell nanoparticles
controlled drug release
BMP-2
PLGA nanoparticles
Pluronic F68
oxaliplatin
hydrogel
intra-abdominal anti-adhesion barrier
colorectal cancer
experimental design
fractional factorial design
O6-methylguanine DNA methyltransferase (MGMT) protein
glioblastoma multiforme
smart nanocarriers
folic acid
verteporfin
cisplatin
SKOV-3 cells
CHO-K1 cells
electroporation
theranostic cargo
double emulsion approach
NSAIDs
polymeric film
topical drug delivery
trolamine salicylate
triamcinolone acetonide
microcrystal
PLGA microsphere
local delivery
spray-drying technique
intra-articular injection
joint retention
systemic exposure
gadolinium
drug release
polymeric nanocarrier
sorafenib
theranostic nanoparticles
PLGA-PEG
nanoparticles
platelet
activation
aggregation
binding
uptake
tissue engineering
Huntington's disease
siRNA
microcarriers
mesenchymal stromal cells
drug delivery systems
microfluidics
microparticles
BMP-2-microspheres
hydrogel system
17-βestradiol release
bone regeneration
osteoporosis
poly-lactide-co-glycolide
polylactic acid
alginate
ophthalmic drug delivery
dexamethasone
PLGA-NPs
nanomedicine
gastrointestinal tract
paclitaxel
in vivo imaging
controlled release
risperidone
microcapsules
oleogels
electron microscopy
three-dimensional X-ray imaging
nano-CT
biodegradable polymers
hydroxy-stearic acid
PLGA nanocapsules
magnetic resonance imaging
photoluminescence
magnetic targeting
multimodal imaging
theranostics
silicon
microsphere
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124003321
Pereira Maria Carmo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Polymeric Carriers for Biomedical and Nanomedicine Application
Polymeric Carriers for Biomedical and Nanomedicine Application
Autore Lima Sofia
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (186 p.)
Soggetto topico Technology: general issues
Soggetto non controllato osteoarthritis
monosodium iodoacetate
p47phox
PLGA nanoparticles
reactive oxygen species
full factorial design
optimization
metronidazole
nanocomposites
sodium alginate
chitosan
PLGA
hybrid polymers
chitosan-PLGA polymer
NMR
DSC
FT-IR
covalent drug conjugation
therapeutic nanodevice
polymeric nanoparticles
cancer therapy
controlled drug delivery
redox responsive PEG-block-PLA
nanocarriers
disulfide bond
controlled release
retinol
nanosponge
hydrogel
Box-Behnken design
pharmacokinetic
terbinafine hydrogel
niacinamide
polyethene glycol (PEG) 400
solvent
dermal delivery
finite dose
porcine skin
dissolving microneedles
multiple sclerosis
PLP
transdermal delivery
tyrosol
nanoparticles
Design of Experiment (DoE)
β cyclodextrin
DNA binding
glyconanoparticles
immunotherapy
infectious diseases
mannose receptors
nutraceuticals
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557739303321
Lima Sofia  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui